Table 3

Survival analyses for gender

GroupPemetrexed + cisplatin survival, median (mo)Cisplatin alone survival, median (mo)P (log rank)
Female randomized and treated (n = 83)15.77.50.012
Female fully folic acid/vitamin B12 supplemented (n = 61)18.97.40.01
Male randomized and treated (n = 365)119.40.176
Male fully folic acid/vitamin B12supplemented (n = 270)12.810.40.388